Recruiting Asthma Studies in Ann Arbor
Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care
ANCHOR is a prospective, multi-center, phase IV, interventional, single-arm, open-label study of 2,000 adult participants with symptomatic asthma requiring the use of rescue therapy aimed to compare t...
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Moderatetosevere Asthma.
This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with moderate-to-severe asthma who have previously completed the parent ...
About Asthma Clinical Trials in Ann Arbor
Asthma is a chronic respiratory condition where the airways become inflamed and narrow, causing difficulty breathing, wheezing, and coughing. It affects over 300 million people worldwide. Treatment includes inhaled corticosteroids, bronchodilators, and biologics for severe asthma.
There are currently 2 asthma clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 2,530 participants. Research is being sponsored by AstraZeneca, Sanofi. Clinical trial participation is free and participants receive study-related medical care at no cost.
Asthma Clinical Trials in Ann Arbor — FAQ
Are there asthma clinical trials in Ann Arbor?
Yes, there are 2 asthma clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ann Arbor?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.
Are clinical trials in Ann Arbor free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.
What asthma treatments are being tested?
The 2 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for asthma.
Data updated March 2, 2026 from ClinicalTrials.gov